Department of Pediatrics and Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY, USA.
J Allergy Clin Immunol. 2012 Jan;129(1):162-8.e1-3. doi: 10.1016/j.jaci.2011.09.018. Epub 2011 Oct 22.
Anaphylaxis incidence is increasing.
We sought to characterize anaphylaxis in children in an urban pediatric emergency department (PED).
We performed a review of PED records for anaphylactic reactions over 5 years.
We identified 213 anaphylactic reactions in 192 children (97 male patients): 6 were infants, 20 had multiple reactions, and the median age was 8 years (age range, 4 months to 18 years). Sixty-two reactions were coded as anaphylaxis; 151 additional reactions met the second symposium anaphylaxis criteria. There was no increase in incidence over 5 years. The triggers included the following: foods, 71%; unknown, 15%; drugs, 9%; and "other," 5%. Food was more likely to be a trigger in multiple PED visits (P = .03). Epinephrine was administered in 169 (79%) reactions; in 58 (27%) reactions epinephrine was administered before arrival in the PED. Patients with Medicaid were less likely to receive epinephrine before arrival in the PED (P < .001). Twenty-eight (14.6%) patients were hospitalized, 9 in the intensive care unit. For 13 (6%) of the reactions, 2 doses of epinephrine were administered; 69% of the patients treated with 2 doses of epinephrine were hospitalized compared with 12% of the patients treated with a single dose (P < .001). Administration of both epinephrine doses before arrival to the PED was associated with a lower rate of hospitalization compared with epinephrine administration in the PED (P = .05).
Food is the main anaphylaxis trigger in the urban PED, although the International Classification of Diseases-ninth revision code for anaphylaxis is underused. Treatment with 2 doses of epinephrine is associated with a higher risk of hospitalization; epinephrine treatment before arrival to the PED is associated with a decreased risk. Children with Medicaid are less likely to receive epinephrine before arrival in the PED.
过敏反应的发病率正在上升。
我们旨在描述城市儿科急诊部门(PED)中儿童过敏反应的特征。
我们对 5 年来 PED 中过敏反应的记录进行了回顾。
我们在 192 名儿童中确定了 213 例过敏反应(6 例为婴儿,20 例有多次反应,中位年龄为 8 岁[年龄范围为 4 个月至 18 岁])。62 例反应被编码为过敏反应;151 例额外的反应符合第二次过敏反应研讨会标准。在 5 年内,发病率没有增加。触发因素包括以下几种:食物(71%)、未知(15%)、药物(9%)和“其他”(5%)。在多次 PED 就诊中,食物更有可能成为触发因素(P =.03)。在 169 例(79%)反应中给予了肾上腺素;在 58 例(27%)反应中,肾上腺素在到达 PED 之前就已给予。有医疗补助的患者在到达 PED 之前接受肾上腺素治疗的可能性较小(P <.001)。28 例(14.6%)患者住院,其中 9 例在重症监护病房。对于 13 例(6%)反应,给予了 2 剂肾上腺素;与接受单剂量肾上腺素治疗的患者(12%)相比,接受 2 剂肾上腺素治疗的患者(69%)住院的比例更高(P <.001)。与在 PED 中给予肾上腺素相比,在到达 PED 之前给予 2 剂肾上腺素与较低的住院率相关(P =.05)。
食物是城市 PED 中过敏反应的主要触发因素,尽管过敏反应的国际疾病分类第九版代码未被充分使用。使用 2 剂肾上腺素治疗与更高的住院风险相关;在到达 PED 之前进行肾上腺素治疗与降低风险相关。有医疗补助的儿童在到达 PED 之前接受肾上腺素治疗的可能性较小。